Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet

Lycopene (LY) belongs to carotenoids and is abundant in red fruits and vegetables. Several previous studies suggested that LY is beneficial for ameliorating non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are unclear. The present study aimed to clarify the potential mechani...

Full description

Bibliographic Details
Main Authors: Xiang Gao, Xia Zhao, Min Liu, Huimin Zhao, Yongye Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1120254/full
_version_ 1797862093729300480
author Xiang Gao
Xiang Gao
Xia Zhao
Min Liu
Huimin Zhao
Yongye Sun
author_facet Xiang Gao
Xiang Gao
Xia Zhao
Min Liu
Huimin Zhao
Yongye Sun
author_sort Xiang Gao
collection DOAJ
description Lycopene (LY) belongs to carotenoids and is abundant in red fruits and vegetables. Several previous studies suggested that LY is beneficial for ameliorating non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are unclear. The present study aimed to clarify the potential mechanisms of LY in preventing NAFLD via exploring the hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota composition in high-fat and high-fructose diet (HFFD)-fed mice. Fifty eight-week-old male C57BL/6J mice were randomly assigned into 5 groups: Normal control group (NC); HFFD group; HFFD with low dose of lycopene group (LLY, 20 mg/kg/d); HFFD with high dose of lycopene group (HLY, 60 mg/kg/d) and HFFD with resveratrol group (RSV, 50 mg/kg/d, positive control). After 8 weeks, feces were collected and the 12 h fasted mice were sacrificed to acquire tissues and blood for parameters measurement. The results showed that the mice in LLY, HLY and RSV groups had significantly lower body weight gain, weight of white adipose tissue, serum levels of high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), lipopolysaccharide (LPS), alanine aminotransferase (ALT), and hepatic concentrations of triglyceride (TG) and interleukin-6 (IL-6) than that in the HFFD group (p < 0.05). HLY and RSV groups also displayed lower serum levels of TG, total cholesterol (TC) and hepatic levels of tumor necrosis factor-α (TNF-α) than the HFFD group (p < 0.05). Liver protein expressions of NLRP3, Pro-Caspase-1, Caspase-1 and NF-κB were lower in the LLY, HLY and RSV groups than those in the HFFD group (p < 0.05). The feces of LY -treated mice had higher relative levels of SCFAs producing bacteria Allobaculum and lower destructive bacteria, including Firmicutes, Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes over the HFFD group (p < 0.05). RSV group also displayed lower fecal levels of Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes than the HFFD group (p < 0.05). In conclusion, LY might prevent NAFLD by suppressing hepatic NF-κB/NLRP3 inflammasome pathway and attenuating gut microbiota dysbiosis.
first_indexed 2024-04-09T22:13:44Z
format Article
id doaj.art-40edcdabf290473c81192f24241cdd4f
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-09T22:13:44Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-40edcdabf290473c81192f24241cdd4f2023-03-23T04:56:41ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-03-011010.3389/fnut.2023.11202541120254Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose dietXiang Gao0Xiang Gao1Xia Zhao2Min Liu3Huimin Zhao4Yongye Sun5Institute of Nutrition and Health, College of Public Health, Qingdao University, Qingdao, ChinaCollege of Life Sciences, Qingdao University, Qingdao, ChinaDepartment of Pediatric Dentistry, Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao, ChinaDepartment of Diet and Nutrition, Shandong Provincial Chronic Disease Hospital, Qingdao, ChinaInstitute of Nutrition and Health, College of Public Health, Qingdao University, Qingdao, ChinaInstitute of Nutrition and Health, College of Public Health, Qingdao University, Qingdao, ChinaLycopene (LY) belongs to carotenoids and is abundant in red fruits and vegetables. Several previous studies suggested that LY is beneficial for ameliorating non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are unclear. The present study aimed to clarify the potential mechanisms of LY in preventing NAFLD via exploring the hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota composition in high-fat and high-fructose diet (HFFD)-fed mice. Fifty eight-week-old male C57BL/6J mice were randomly assigned into 5 groups: Normal control group (NC); HFFD group; HFFD with low dose of lycopene group (LLY, 20 mg/kg/d); HFFD with high dose of lycopene group (HLY, 60 mg/kg/d) and HFFD with resveratrol group (RSV, 50 mg/kg/d, positive control). After 8 weeks, feces were collected and the 12 h fasted mice were sacrificed to acquire tissues and blood for parameters measurement. The results showed that the mice in LLY, HLY and RSV groups had significantly lower body weight gain, weight of white adipose tissue, serum levels of high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), lipopolysaccharide (LPS), alanine aminotransferase (ALT), and hepatic concentrations of triglyceride (TG) and interleukin-6 (IL-6) than that in the HFFD group (p < 0.05). HLY and RSV groups also displayed lower serum levels of TG, total cholesterol (TC) and hepatic levels of tumor necrosis factor-α (TNF-α) than the HFFD group (p < 0.05). Liver protein expressions of NLRP3, Pro-Caspase-1, Caspase-1 and NF-κB were lower in the LLY, HLY and RSV groups than those in the HFFD group (p < 0.05). The feces of LY -treated mice had higher relative levels of SCFAs producing bacteria Allobaculum and lower destructive bacteria, including Firmicutes, Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes over the HFFD group (p < 0.05). RSV group also displayed lower fecal levels of Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes than the HFFD group (p < 0.05). In conclusion, LY might prevent NAFLD by suppressing hepatic NF-κB/NLRP3 inflammasome pathway and attenuating gut microbiota dysbiosis.https://www.frontiersin.org/articles/10.3389/fnut.2023.1120254/fulllycopeneNLRP3nonalcoholic fatty liver diseaseintestinal microbiotamice
spellingShingle Xiang Gao
Xiang Gao
Xia Zhao
Min Liu
Huimin Zhao
Yongye Sun
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
Frontiers in Nutrition
lycopene
NLRP3
nonalcoholic fatty liver disease
intestinal microbiota
mice
title Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
title_full Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
title_fullStr Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
title_full_unstemmed Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
title_short Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
title_sort lycopene prevents non alcoholic fatty liver disease through regulating hepatic nf κb nlrp3 inflammasome pathway and intestinal microbiota in mice fed with high fat and high fructose diet
topic lycopene
NLRP3
nonalcoholic fatty liver disease
intestinal microbiota
mice
url https://www.frontiersin.org/articles/10.3389/fnut.2023.1120254/full
work_keys_str_mv AT xianggao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet
AT xianggao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet
AT xiazhao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet
AT minliu lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet
AT huiminzhao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet
AT yongyesun lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet